Bayer Crop Science Intrinsic Value
Bayer Crop Science (BAYERCROP) median intrinsic value is ₹1352.85 from 9 valuation models (range ₹902–₹2255), vs current price ₹4509.50 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse Bayer Crop Science annual reports for revenue, profit, balance sheet and cash flow data.
BAYERCROP Valuation Methods Summary — DCF, Graham Number & P/E
Bayer Crop Science intrinsic value across 9 models vs current price ₹4509.50 — upside/downside and value range per method. Also explore Bayer Crop Science share price performance to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1516.56 | ₹1213.25 - ₹1819.87 | -66.4% | EPS: ₹126.38, Sector P/E: 12x |
| Book Value Method | asset | ₹901.90 | ₹811.71 - ₹992.09 | -80.0% | Book Value/Share: ₹659.11, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1352.85 | ₹1217.57 - ₹1488.13 | -70.0% | Revenue/Share: ₹1242.89, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1803.80 | ₹1623.42 - ₹1984.18 | -60.0% | EBITDA: ₹809.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹1803.80 | ₹1443.04 - ₹2164.56 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹1352.85 | ₹1217.57 - ₹1488.13 | -70.0% | EPS Growth: 3.6%, Fair P/E: 2.9x |
| Growth Adjusted P/E | growth | ₹1352.85 | ₹1217.57 - ₹1488.13 | -70.0% | Revenue Growth: 6.6%, Adj P/E: 8.3x |
| ROE Based Valuation | profitability | ₹2254.75 | ₹2029.28 - ₹2480.23 | -50.0% | ROE: 19.2%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹1352.85 | ₹1217.57 - ₹1488.13 | -70.0% | EPS: ₹126.38, BVPS: ₹659.11 |
BAYERCROP Intrinsic Value vs Market Price — All Valuation Models
Bayer Crop Science fair value range ₹902–₹2255 vs current market price ₹4509.50 across 9 valuation models. For current market price and key ratios, visit Bayer Crop Science share price chart.
BAYERCROP Intrinsic Value Analysis — Undervalued or Overvalued?
Bayer Crop Science median intrinsic value ₹1352.85, current price ₹4509.50 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of BAYERCROP?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Bayer Crop Science (BAYERCROP) is ₹1352.85 (median value). With the current market price of ₹4509.50, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹901.90 to ₹2254.75, indicating ₹901.90 - ₹2254.75.
Is BAYERCROP undervalued or overvalued?
Based on our multi-method analysis, Bayer Crop Science (BAYERCROP) appears to be trading above calculated value by approximately 70.0%.
BAYERCROP Financial Health — Key Ratios vs Industry Benchmarks
Bayer Crop Science financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 29.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 19.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.98x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
BAYERCROP Cash Flow Quality — Operating & Free Cash Flow
Bayer Crop Science operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹262 Cr | ₹262 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹952 Cr | ₹952 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹609 Cr | ₹609 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹216 Cr | ₹216 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹687 Cr | ₹687 Cr | Positive Free Cash Flow | 8/10 |